Ahmed M, Zaghloul N, Zimmerman P, Casanova NG, Sun X, Reyes Hernon V, et al. Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb. Pulm Circ. 2021;11(4):20458940211059712.
Google Scholar
Chen J, Sysol JR, Singla S, Zhao S, Yamamura A, Valdez-Jasso D, et al. Nicotinamide phosphoribosyltransferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension. Circulation. 2017;135(16):1532–46.
Google Scholar
Sun X, Sun BL, Babicheva A, Vanderpool R, Oita RC, Casanova N, et al. Direct extracellular NAMPT involvement in pulmonary hypertension and vascular remodeling. Transcriptional regulation by SOX and HIF-2alpha. Am J Respir Cell Mol Biol. 2020;63(1):92–103.
Google Scholar
Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal. 2021;34(12):891–914.
Google Scholar
Pillai VB, Sundaresan NR, Kim G, Samant S, Moreno-Vinasco L, Garcia JG, et al. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling. Am J Physiol Heart Circ Physiol. 2013;304(3):H415-26.
Google Scholar
Oita RC, Camp SM, Ma W, Ceco E, Harbeck M, Singleton P, et al. Novel mechanism for nicotinamide phosphoribosyltransferase Inhibition of TNF-alpha-mediated apoptosis in human lung endothelial cells. Am J Respir Cell Mol Biol. 2018;59(1):36–44.
Google Scholar
Casanova NG, Herazo-Maya J, Kempf CL, Sun BL, Song JH, Hernandez A et al. eNAMPT is a novel DAMP and therapeutic target in human and murine pulmonary fibrosis. . Am J Respir Cell Mol Biol. 2025.
Quijada H, Bermudez T, Kempf CL, Valera DG, Garcia AN, Camp SM et al. Endothelial eNAMPT amplifies preclinical acute lung injury: efficacy of an eNAMPT-Neutralising mAb. Eur Respir J. 2021;57(5):2002536.
Bao C, Liang S, Han Y, Yang Z, Liu S, Sun Y, et al. The novel lysosomal autophagy inhibitor (ROC-325) ameliorates experimental pulmonary hypertension. Hypertension. 2023;80(1):70–83.
Google Scholar
Tang C, Luo Y, Li S, Huang B, Xu S, Li L. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Biomed Pharmacother. 2021;133:111081.
Google Scholar
Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics. 2008;33(2):278–91.
Google Scholar
Tang H, Babicheva A, McDermott KM, Gu Y, Ayon RJ, Song S, et al. Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol. 2018;314(2):L256–75.
Google Scholar
Guo M, Morley MP, Jiang C, Wu Y, Li G, Du Y, et al. Guided construction of single cell reference for human and mouse lung. Nat Commun. 2023;14(1):4566.
Google Scholar
Tsukui T, Sun KH, Wetter JB, Wilson-Kanamori JR, Hazelwood LA, Henderson NC, et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun. 2020;11(1):1920.
Google Scholar
Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, stringtie and ballgown. Nat Protoc. 2016;11(9):1650–67.
Google Scholar
Miller SA, Policastro RA, Sriramkumar S, Lai T, Huntington TD, Ladaika CA, et al. LSD1 and aberrant DNA methylation mediate persistence of enteroendocrine progenitors that support BRAF-mutant colorectal cancer. Cancer Res. 2021;81(14):3791–805.
Google Scholar
Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, et al. Capillary cell-type specialization in the alveolus. Nature. 2020;586(7831):785–9.
Google Scholar
Liu B, Yi D, Xia X, Ramirez K, Zhao H, Cao Y, et al. General capillary endothelial cells undergo reprogramming into arterial endothelial cells in pulmonary hypertension through HIF-2alpha/Notch4 pathway. Circulation. 2024;150(5):414–7.
Google Scholar
Man S, Sanchez Duffhues G, Ten Dijke P, Baker D. The therapeutic potential of targeting the endothelial-to-mesenchymal transition. Angiogenesis. 2019;22(1):3–13.
Google Scholar
Hong J, Arneson D, Umar S, Ruffenach G, Cunningham CM, Ahn IS, et al. Single-cell study of two rat models of pulmonary arterial hypertension reveals connections to human pathobiology and drug repositioning. Am J Respir Crit Care Med. 2021;203(8):1006–22.
Google Scholar
Tarhan L, Bistline J, Chang J, Galloway B, Hanna E, Weitz E. Single cell portal: an interactive home for single-cell genomics data. bioRxiv. 2023. https://doi.org/10.1101/2023.07.13.548886.
Google Scholar
Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165–75.
Google Scholar
Ahmed M, Casanova NG, Zaghloul N, Gupta A, Rodriguez M, Robbins IR, et al. The eNAMPT/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes. Front Physiol. 2023;14:1129413.
Google Scholar
Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN. Strategies to dampen COVID-19-mediated lung and systemic inflammation and vascular injury. Transl Res. 2021;232:374–8. https://doi.org/10.1016/j.trsl.2020.12.008.
Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, Watanabe M, Tsuji-Hosokawa A, et al. eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes. Diabetologia. 2024;67(9):1998–2011.
Google Scholar
Sun BL, Sun X, Casanova N, Garcia AN, Oita R, Algotar AM, et al. Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: novel biomarker and therapeutic target. EBioMedicine. 2020;61:103059.
Google Scholar
Sun BL, Sun X, Kempf CL, Song JH, Casanova NG, Camp SM, et al. Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis. FASEB J. 2023;37(3):e22825.
Google Scholar
Tumurkhuu G, Casanova NG, Kempf CL, Ercan Laguna D, Camp SM, Dagvadorj J, et al. eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE lung vasculitis and alveolar hemorrhage. J Transl Autoimmun. 2023;6:100181.
Google Scholar
Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005;171(4):361–70.
Google Scholar
Alvandi Z, Bischoff J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357–69.
Google Scholar
Huang J, Pu Y, Zhang H, Xie L, He L, Zhang CL, et al. KLF2 mediates the suppressive effect of laminar flow on vascular calcification by inhibiting endothelial BMP/SMAD1/5 signaling. Circ Res. 2021;129(4):e87-100.
Google Scholar
Kang K, Xiang J, Zhang X, Xie Y, Zhou M, Zeng L, et al. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. Cell Mol Biol Lett. 2024;29(1):69.
Google Scholar
Zhang-Sun ZY, Xu XZ, Escames G, Lei WR, Zhao L, Zhou YZ, et al. Targeting NR1D1 in organ injury: challenges and prospects. Mil Med Res. 2023;10(1):62.
Google Scholar
Chae WJ, Bothwell ALM. Canonical and non-canonical Wnt signaling in immune cells. Trends Immunol. 2018;39(10):830–47.
Google Scholar
Sun L, Xing J, Zhou X, Song X, Gao S. Wnt/beta-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells. Biomed Pharmacother. 2024;175:116685.
Google Scholar
Tang H, Wu K, Wang J, Vinjamuri S, Gu Y, Song S, et al. Pathogenic role of mTORC1 and mTORC2 in pulmonary hypertension. JACC Basic Transl Sci. 2018;3(6):744–62.
Google Scholar
Lowe M, Lage J, Paatela E, Munson D, Hostager R, Yuan C, et al. Cry2 is critical for circadian regulation of myogenic differentiation by Bclaf1-mediated mRNA stabilization of Cyclin D1 and Tmem176b. Cell Rep. 2018;22(8):2118–32.
Google Scholar
Bryant AJ, Ebrahimi E, Nguyen A, Wolff CA, Gumz ML, Liu AC, Esser KA. A wrinkle in time: circadian biology in pulmonary vascular health and disease. Am J Physiol Lung Cell Mol Physiol. 2022;322(1):L84–101.
Google Scholar
Lopez-Moncada F, Torres MJ, Lavanderos B, Cerda O, Castellon EA, Contreras HR. SPARC induces E-Cadherin repression and enhances cell migration through integrin alphavbeta3 and the transcription factor ZEB1 in prostate cancer cells. Int J Mol Sci. 2022;23(11):5874. https://doi.org/10.3390/ijms23115874.
Dean A, Gregorc T, Docherty CK, Harvey KY, Nilsen M, Morrell NW, et al. Role of the aryl hydrocarbon receptor in Sugen 5416-induced experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2018;58(3):320–30.
Google Scholar
Liang S, Guo H, Ma K, Li X, Wu D, Wang Y, et al. A PLCB1-PI3K-AKT signaling axis activates EMT to promote cholangiocarcinoma progression. Cancer Res. 2021;81(23):5889–903.
Google Scholar
Karoor V, Fini MA, Loomis Z, Sullivan T, Hersh LB, Gerasimovskaya E, et al. Sustained activation of Rho GTPases promotes a synthetic pulmonary artery smooth muscle cell phenotype in Neprilysin null mice. Arterioscler Thromb Vasc Biol. 2018;38(1):154–63.
Google Scholar
Alexander MR, Murgai M, Moehle CW, Owens GK. Interleukin-1beta modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-kappaB-dependent mechanisms. Physiol Genomics. 2012;44(7):417–29.
Google Scholar
Cho DI, Ahn MJ, Cho HH, Cho M, Jun JH, Kang BG, et al. Angptl4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulation. Exp Mol Med. 2023;55(2):426–42.
Google Scholar
Cheung AK, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci U S A. 2011;108(20):8390–5.
Google Scholar
Yang L, Zhou F, Zheng D, Wang D, Li X, Zhao C, Huang X. FGF/FGFR signaling: from lung development to respiratory diseases. Cytokine Growth Factor Rev. 2021;62:94–104.
Google Scholar
Wen Z, Jiang L, Yu F, Xu X, Chen M, Li C, et al. ScrNA-seq reveals NAMPT-mediated macrophage polarization shapes smooth muscle cell plasticity in pulmonary arterial hypertension. Interdiscip Med. 2024;2(4):e20240016.
Google Scholar
Streef TJ, Groeneveld EJ, van Herwaarden T, Hjortnaes J, Goumans MJ, Smits AM. Single-cell analysis of human fetal epicardium reveals its cellular composition and identifies CRIP1 as a modulator of EMT. Stem Cell Reports. 2023;18(7):1421–35.
Google Scholar
Ahmed MN, Zhang Y, Codipilly C, Zaghloul N, Patel D, Wolin M, Miller EJ. Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Mol Med. 2012;18:38–46.
Google Scholar
Tarazona S, Furio-Tari P, Turra D, Pietro AD, Nueda MJ, Ferrer A, et al. Data quality aware analysis of differential expression in RNA-seq with NOIseq r/bioc package. Nucleic Acids Res. 2015;43(21):e140.
Google Scholar
Zawia A, Arnold ND, West L, Pickworth JA, Turton H, Iremonger J, et al. Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2021;41(1):430–45.
Google Scholar
Qiu H, He Y, Ouyang F, Jiang P, Guo S, Guo Y. The role of regulatory T cells in pulmonary arterial hypertension. J Am Heart Assoc. 2019;8(23):e014201.
Google Scholar
Rodriguez M, Xu H, Hernandez A, Ingraham J, Canizales Galaviz J, Teran Arce F et al. NEDD4 E3 ligase-catalyzed NAMPT ubiquitination and autophagy are essential for pyroptosis-independent NAMPT secretion in human monocytes. Cell Commun Signal. 2025;23:157 https://doi.org/10.1186/s12964-025-02164-5.
Audrito V, Serra S, Brusa D, Mazzola F, Arruga F, Vaisitti T, et al. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood. 2015;125(1):111–23.
Google Scholar
Wang Z, Li W, Chen S, Tang XX. Role of ADAM and ADAMTS proteases in pathological tissue remodeling. Cell Death Discov. 2023;9(1):447.
Google Scholar
Hudalla H, Michael Z, Christodoulou N, Willis GR, Fernandez-Gonzalez A, Filatava EJ, et al. Carbonic anhydrase inhibition ameliorates inflammation and experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2019;61(4):512–24.
Google Scholar
Zhu Y, Dun H, Ye L, Terada Y, Shriver LP, Patti GJ et al. Targeting fatty acid beta-oxidation impairs monocyte differentiation and prolongs heart allograft survival. JCI Insight. 2022;7(7):e151596. https://doi.org/10.1172/jci.insight.151596.
Tyrrell C, De Cecco M, Reynolds NL, Kilanowski F, Campopiano D, Barran P, et al. Isoleucine/leucine2 is essential for chemoattractant activity of beta-defensin Defb14 through chemokine receptor 6. Mol Immunol. 2010;47(6):1378–82.
Google Scholar
Cai X, Deng J, Ming Q, Cai H, Chen Z. Chemokine-like factor 1: a promising therapeutic target in human diseases. Exp Biol Med (Maywood). 2020;245(16):1518–28.
Google Scholar
Liao Y, Deng C, Wang X. VSIG4 ameliorates intestinal inflammation through inhibiting macrophages NLRP3 inflammasome and pyroptosis. Tissue Cell. 2024;86:102285.
Google Scholar
Li R, Chen B, Kubota A, Hanna A, Humeres C, Hernandez SC, et al. Protective effects of macrophage-specific integrin alpha5 in myocardial infarction are associated with accentuated angiogenesis. Nat Commun. 2023;14(1):7555.
Google Scholar
Jairath V, Acosta Felquer ML, Cho RJ. IL-23 inhibition for chronic inflammatory disease. Lancet. 2024;404(10463):1679–92.
Google Scholar
Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135(2):112–24.
Google Scholar
Garcia AN, Casanova NG, Valera DG, Sun X, Song JH, Kempf CL, et al. Involvement of eNAMPT/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization. Transl Res. 2022;239:44–57.
Google Scholar
Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol. 2009;54(1 Suppl):S10–9.
Google Scholar
Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, et al. Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin Microbiol Infect. 2011;17(1):7–14.
Google Scholar
Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122(9):920–7.
Google Scholar
Wang J, Tian XT, Peng Z, Li WQ, Cao YY, Li Y, Li XH. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling. Vascul Pharmacol. 2019;117:35–44.
Google Scholar
Xiao G, Zhuang W, Wang T, Lian G, Luo L, Ye C, et al. Transcriptomic analysis identifies toll-like and nod-like pathways and necroptosis in pulmonary arterial hypertension. J Cell Mol Med. 2020;24(19):11409–21.
Google Scholar
Young KC, Hussein SM, Dadiz R, deMello D, Devia C, Hehre D, et al. Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension. Exp Lung Res. 2010;36(2):111–9.
Google Scholar
Dai Z, Li M, Wharton J, Zhu MM, Zhao YY. Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2alpha. Circulation. 2016;133(24):2447–58.
Google Scholar
